{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T11:38:58Z","timestamp":1793619538935,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI11-02800"],"award-info":[{"award-number":["PI11-02800"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI11-01357"],"award-info":[{"award-number":["PI11-01357"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI14-00165"],"award-info":[{"award-number":["PI14-00165"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Development Regional Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Spanish Network for the Research in Infectious Diseases","award":["REIPI RD12\/0015\/0001"],"award-info":[{"award-number":["REIPI RD12\/0015\/0001"]}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/j.cmi.2018.09.019","type":"journal-article","created":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T23:54:06Z","timestamp":1538697246000},"page":"753-758","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Impact of pretransplant CMV-specific T-cell immune response in the control of CMV infection after solid organ transplantation: a prospective cohort study"],"prefix":"10.1016","volume":"25","author":[{"given":"A.","family":"Molina-Ortega","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mart\u00edn-Gandul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.D.","family":"Mena-Romo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.J.","family":"Rodr\u00edguez-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Su\u00f1er","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Bernal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"S\u00e1nchez-C\u00e9spedes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"P\u00e9rez Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Cordero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2018.09.019_bib1","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.trre.2016.04.001","article-title":"Management of cytomegalovirus infection in solid organ transplant recipients: SET\/GESITRA-SEIMC\/REIPI recommendations","volume":"30","author":"Torre-Cisneros","year":"2016","journal-title":"Transplant Rev (Orlando)"},{"issue":"Suppl 4","key":"10.1016\/j.cmi.2018.09.019_bib2","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/ajt.12103","article-title":"Cytomegalovirus in solid organ transplantation","volume":"13","author":"Razonable","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2018.09.019_bib3","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1097\/TP.0b013e31829df29d","article-title":"Updated international consensus guidelines on the management of cytomegalovirus in solid-organ transplantation","volume":"96","author":"Kotton","year":"2013","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.09.019_bib4","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.TP.0000145989.22373.03","article-title":"Late-onset cytomegalovirus disease in liver transplant recipients despite antiviral prophylaxis","volume":"78","author":"Limaye","year":"2004","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.09.019_bib5","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.tp.0000226071.12562.1a","article-title":"Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis","volume":"81","author":"Limaye","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.09.019_bib6","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1086\/605634","article-title":"Toward the individualization of cytomegalovirus control after solid-organ transplantation: the importance of the \u201cindividual pathogenic balance\u201d","volume":"49","author":"Torre-Cisneros","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.09.019_bib7","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1097\/TP.0b013e3182115ba2","article-title":"Therapeutic effect of the acquisition of cytomegalovirus-specific immune response during preemptive treatment","volume":"91","author":"Benmarzouk-Hidalgo","year":"2011","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.09.019_bib8","doi-asserted-by":"crossref","first-page":"11538","DOI":"10.1128\/JVI.00581-07","article-title":"Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8(+) T-cell response","volume":"81","author":"Crough","year":"2007","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.cmi.2018.09.019_bib9","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1111\/j.1600-6143.2005.00871.x","article-title":"Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation","volume":"5","author":"Sester","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2018.09.019_bib10","first-page":"336","article-title":"CMV-specific T-cell immunity in solid organ transplant recipients at low risk of CMV infection. Chronology and applicability in preemptive therapy","volume":"75","author":"Mena-Romo","year":"2017","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.cmi.2018.09.019_bib11","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1111\/j.1600-6143.2009.02618.x","article-title":"Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients","volume":"9","author":"Kumar","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2018.09.019_bib12","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/cid\/cis993","article-title":"Assessment of cytomegalovirus-specific cell-mediated immunity for the prediction of cytomegalovirus disease in high-risk solid-organ transplant recipients: a multicenter cohort study","volume":"56","author":"Manuel","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.09.019_bib13","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/01.TP.0000438025.96334.eb","article-title":"Pretransplant CD8 T-cell response to IE-1 discriminates seropositive kidney recipients at risk of developing CMV infection posttransplant","volume":"97","author":"Lopez-Oliva","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.09.019_bib14","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1111\/ajt.12256","article-title":"Pretransplant immediately early-1-specific T cell responses provide protection for CMV infection after kidney transplantation","volume":"13","author":"Bestard","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2018.09.019_bib15","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1111\/ajt.12388","article-title":"Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients","volume":"13","author":"Manuel","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2018.09.019_bib16","doi-asserted-by":"crossref","first-page":"2457","DOI":"10.1111\/j.1600-6143.2012.04087.x","article-title":"Cytomegalovirus replication kinetics in solid organ transplant recipients managed by preemptive therapy","volume":"12","author":"Atabani","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2018.09.019_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-6143.2009.02861.x","article-title":"Clinical predictors of relapse after treatment of primary gastrointestinal cytomegalovirus disease in solid organ transplant recipients","volume":"10","author":"Eid","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2018.09.019_bib18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1086\/511307","article-title":"Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease","volume":"195","author":"La Rosa","year":"2007","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.cmi.2018.09.019_bib19","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/MOT.0b013e3283186bbc","article-title":"Hypogammaglobulinemia and infection risk in solid organ transplant recipients","volume":"13","author":"Mawhorter","year":"2008","journal-title":"Curr Opin Organ Transplant"},{"key":"10.1016\/j.cmi.2018.09.019_bib20","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.humimm.2004.02.012","article-title":"Cytomegalovirus (CMV)-specific cellular immune responses","volume":"65","author":"Harari","year":"2004","journal-title":"Hum Immunol"},{"key":"10.1016\/j.cmi.2018.09.019_bib21","first-page":"329","article-title":"Pre-transplant assessment of CMV-specific immune response by Elispot assay in kidney transplant recipients","volume":"38","author":"Ritta","year":"2015","journal-title":"New Microbiol"},{"key":"10.1016\/j.cmi.2018.09.019_bib22","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1086\/339329","article-title":"Definitions of cytomegalovirus infection and disease in transplant recipients","volume":"34","author":"Ljungman","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2018.09.019_bib23","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.jcv.2012.09.017","article-title":"Determination, validation and standardization of a CMV DNA cut-off value in plasma for preemptive treatment of CMV infection in solid organ transplant recipients at lower risk for CMV infection","volume":"56","author":"Martin-Gandul","year":"2013","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.cmi.2018.09.019_bib24","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1097\/01.TP.0000083894.61333.56","article-title":"Is the cytomegalovirus serologic status always accurate? A comparative analysis of humoral and cellular immunity","volume":"76","author":"Sester","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.09.019_bib25","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/ajt.13012","article-title":"Factors related to the development of CMV-specific CD8+ T cell response in CMV-seropositive solid organ transplant candidates","volume":"15","author":"Cantisan","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2018.09.019_bib26","doi-asserted-by":"crossref","first-page":"e315","DOI":"10.1097\/TP.0000000000001825","article-title":"CMV-specific T cell monitoring offers superior risk stratification of CMV-seronegative kidney transplant recipients of a CMV-seropositive donor","volume":"101","author":"Schachtner","year":"2017","journal-title":"Transplantation"},{"key":"10.1016\/j.cmi.2018.09.019_bib27","first-page":"597","article-title":"Use of antibodies neutralizing epithelial cell infection to diagnose patients at risk for CMV Disease after transplantation","volume":"72","author":"Blanco-Lobo","year":"2016","journal-title":"J\u00a0Infect"},{"issue":"Suppl 1","key":"10.1016\/j.cmi.2018.09.019_bib28","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/ajt.12581","article-title":"OPTN\/SRTR 2012 annual data report: liver","volume":"14","author":"Kim","year":"2014","journal-title":"Am J Transplant"},{"issue":"Suppl 1","key":"10.1016\/j.cmi.2018.09.019_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/ajt.12579","article-title":"OPTN\/SRTR 2012 annual data report: kidney","volume":"14","author":"Matas","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2018.09.019_bib30","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra011295","article-title":"Strategies to improve long-term outcomes after renal transplantation","volume":"346","author":"Pascual","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2018.09.019_bib31","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1111\/ajt.14192","article-title":"Preventive strategies against cytomegalovirus and incidence of alpha-herpesvirus infections in solid organ transplant recipients: a nationwide cohort study","volume":"17","author":"Martin-Gandul","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/j.cmi.2018.09.019_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13161","article-title":"Revisiting chronic rejection following living donor liver transplantation in the tacrolimus era: a single center experience","volume":"32","author":"Choudhary","year":"2018","journal-title":"Clin Transplant"},{"key":"10.1016\/j.cmi.2018.09.019_bib33","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/cid\/cix793","article-title":"Use of viral load as a surrogate marker in clinical studies of cytomegalovirus in solid organ transplantation: a systematic review and meta-analysis","volume":"66","author":"Natori","year":"2018","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18306578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X18306578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T07:23:01Z","timestamp":1761117781000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X18306578"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S1198743X18306578"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2018.09.019","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of pretransplant CMV-specific T-cell immune response in the control of CMV infection after solid organ transplantation: a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2018.09.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}